Vertex Pharmaceuticals (VRTX) Shares Outstanding (2009 - 2026)

Vertex Pharmaceuticals has reported Shares Outstanding for 18 years, with the latest figure at $254.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding fell 1.1% year-over-year to $254.2 million; the trailing twelve-month figure through Mar 2026 stood at $254.2 million (down 1.1% YoY), and the FY2025 full-year result was $254.0 million, down 1.13% from the prior year.
• Shares Outstanding for Q1 2026 stood at $254.2 million, roughly flat from $254.0 million in the prior quarter.
• The five-year high for Shares Outstanding was $258.3 million in Q1 2024, with the low at $254.0 million in Q3 2025.
• Average Shares Outstanding over 5 years is $256.6 million, with a median of $257.0 million recorded in 2022.
• Year-over-year, Shares Outstanding gained 0.98% in 2022 and retreated 1.45% in 2025.
• Tracing VRTX's Shares Outstanding over 5 years: stood at $257.0 million in 2022, then grew by 0.27% to $257.7 million in 2023, then slipped by 0.31% to $256.9 million in 2024, then dropped by 1.13% to $254.0 million in 2025, then grew by 0.07% to $254.2 million in 2026.
• The last three Shares Outstanding figures came in at $254.2 million (Q1 2026), $254.0 million (Q4 2025), and $254.0 million (Q3 2025), per Business Quant data.

Peer Comparison